TET2 c.469G>A ;(p.E157K)

Variant ID: 4-106155568-G-A

NM_001127208.2(TET2):c.469G>A;(p.E157K)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting.

Bmc Medical Genomics
Wünsch, Christian C; Banck, Henrik H; Müller-Tidow, Carsten C; Dugas, Martin M
Publication Date: 2020-02-04

Variant appearance in text: TET2: 469G>A
PubMed Link: 32019565
Variant Present in the following documents:
  • 12920_2020_668_MOESM5_ESM.xls, sheet 1
View BVdb publication page



TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.

Blood Cancer Journal
Hou, H-A HA; Chou, W-C WC; Kuo, Y-Y YY; Liu, C-Y CY; Lin, L-I LI; Tseng, M-H MH; Chiang, Y-C YC; Liu, M-C MC; Liu, C-W CW; Tang, J-L JL; Yao, M M; Li, C-C CC; Huang, S-Y SY; Ko, B-S BS; Hsu, S-C SC; Chen, C-Y CY; Lin, C-T CT; Wu, S-J SJ; Tsay, W W; Chen, Y-C YC; Tien, H-F HF
Publication Date: 2015-07-31

Variant appearance in text: TET2: 469G>A
PubMed Link: 26230955
Variant Present in the following documents:
  • Main text
View BVdb publication page